Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization | Zendy

Saleem Ahmed | Zendy; Nurun Nisa de Souza | Zendy; Qiao Wang | Zendy; Meidai Kasai | Zendy; Low Jee Keem | Zendy; Vishal G. Shelat | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization

Author(s) -

Saleem Ahmed,

Nurun Nisa de Souza,

Qiao Wang,

Meidai Kasai,

Low Jee Keem,

Vishal G. Shelat

Publication year - 2016

Publication title -

hpb surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.561

H-Index - 26

eISSN - 1607-8462

pISSN - 0894-8569

DOI - 10.1155/2016/6120143

Subject(s) - medicine , hepatocellular carcinoma , quality of life (healthcare) , palliative therapy , palliative treatment , oncology , radiology , gastroenterology , chemotherapy , nursing

Hepatocellular carcinoma (HCC) is one of the most commonly diagnosed cancers worldwide. Majority of patients with HCC are diagnosed in the advanced stages of disease and hence they are only suitable for palliative therapy. TACE (transarterial chemoembolization) is the most commonly used treatment for unresectable HCC. It is however unclear if TACE improves the quality of life (QoL) in patients with HCC. The aim of this review is to evaluate the impact of TACE on QoL of HCC patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research